Nabriva Therapeutics plc
Nabriva Therapeutics plc (NBRVF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NBRVF · as of Jun 9, 2026
Key Statistics
Explore Nabriva Therapeutics plc Data
nbrvf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
nbrvf competitorsNBRVF
BIOCQ
CDXI
ELOX
HTGMQ
MDVLQStock Performance
Full HistoryAbout Nabriva Therapeutics plc
Nabriva Therapeutics plc is a biopharmaceutical firm dedicated to discovering, developing, and commercializing innovative anti-infective medicines for managing serious infections. Its current portfoli…
what is nabriva therapeutics plc · nbrvf stock overview · nabriva therapeutics plc company profile · who is nabriva therapeutics plc ceo · nbrvf OTC · nabriva therapeutics plc headquarters · nabriva therapeutics plc business segments
About Stock Overview & Key Data
Nabriva Therapeutics plc (NBRVF) is a Healthcare company in the Biotechnology industry, listed on OTC since Aug 1, 2023. As of the latest trading session, NBRVF stock price is $0.00, with a market capitalization of $323. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
In fiscal year 2022, Nabriva Therapeutics plc reported revenue of $35.7M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Nabriva Therapeutics plc (NBRVF) stock price is $0.00. The stock is traded on OTC under the ticker symbol NBRVF. The 52-week range is $0.00 – $0.00.